|
Wed, 02/12/2020 - 06:26 |
Shingles vaccine may also reduce stroke risk |
American Heart ... |
|
Mon, 01/14/2019 - 13:26 |
Scilex Announces Addition of ZTlido to Express Scripts National Formularies |
Sorrento Therap... |
|
Thu, 12/13/2018 - 06:35 |
Cancer Patients Face Higher Shingles Risk, New Vaccines Hold Promise for Prevention |
Infectious Dise... |
|
Sun, 12/02/2018 - 23:09 |
New Venclexta Data Demonstrate Deep Responses in Two of the Most Common Types of Leukemia |
Genentech |
|
Mon, 11/26/2018 - 20:32 |
Pfizer Receives Six Months Pediatric Exclusivity for LYRICA (pregabalin) |
Pfizer |
|
Fri, 11/02/2018 - 12:35 |
Chickenpox, also known as varicella, is a disease dreaded by both parents and children alike. |
Lifespan |
|
Sat, 10/27/2018 - 02:17 |
BlueCross BlueShield Breaks Down the Facts about Vaccines |
Blue Cross Blue... |
|
Tue, 10/09/2018 - 17:14 |
OCREVUS (Ocrelizumab) Data Show Early Initiation of Treatment Reduces Disability Progression over Five Years in Relapsing and Primary Progressive Multiple Sclerosis |
Genentech |
|
Mon, 10/01/2018 - 14:43 |
Genentech to Present Five-Year OCREVUS (Ocrelizumab) Efficacy and Safety Data in Relapsing and Primary Progressive Multiple Sclerosis at ECTRIMS |
Genentech |
|
Wed, 09/05/2018 - 20:42 |
Vaccines Market by Key Players Strategies and Market Segmentation | MarketsandMarketsResearchPvtLtd |
MarketsandMarke... |
|
Tue, 09/04/2018 - 22:25 |
Over 50? You Need This Vaccine to Protect Your Vision |
American Academ... |
|
Thu, 08/30/2018 - 20:22 |
Requiring insurers to cover retail pharmacy vaccinations for adult Californians could save lives, study finds |
UCLA |
|
Mon, 07/30/2018 - 05:33 |
American College of Physicians Reminds Adults to Discuss Vaccinations They May Need With Their Internist |
American Colleg... |
|
Wed, 07/25/2018 - 03:06 |
GSK delivers improvements in sales, margins and cash flow in Q2 2018 |
GlaxoSmithKline |
|
Wed, 07/11/2018 - 03:01 |
Genentech Announces Submission of Supplemental New Drug Application for Venclexta for People With Previously Untreated Acute Myeloid Leukemia who are Ineligible for Intensive Chemotherapy |
Genentech |
|
Thu, 06/21/2018 - 18:19 |
Men's Health: Fatherhood, Low-T and Staying Healthy |
Cone Health |
|
Fri, 06/15/2018 - 02:05 |
Herpes Vaccines Flop. What About Drugs? Pritelivir: A Page From The AIDS Playbook |
American Counci... |
|
Wed, 06/13/2018 - 11:06 |
Genentech Announces New Ocrevus (Ocrelizumab) Data on Long-Term Disability Benefits in Primary Progressive Multiple Sclerosis and Initiation of two Global Studies in Progressive MS |
Genentech |
|
Wed, 06/13/2018 - 09:21 |
Adel Mahmoud, global health leader and Princeton faculty member, dies at 76 |
Princeton University |
|
Fri, 06/08/2018 - 11:19 |
Genentech Announces FDA Approval for Venclexta Plus Rituxan for People With Previously Treated Chronic Lymphocytic Leukemia |
Genentech |
|
Wed, 05/30/2018 - 10:47 |
FDA approves new treatment for moderately to severely active ulcerative colitis |
FDA |
|
Thu, 05/17/2018 - 09:00 |
LYRICA (pregabalin) Oral Solution CV Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint |
Pfizer |
|
Tue, 04/24/2018 - 07:53 |
World Immunization Week Recognizes Gains Brought by Vaccines |
Infectious Dise... |
|
Sat, 04/21/2018 - 21:37 |
New OCREVUS (Ocrelizumab) Data at AAN Demonstrate Significant Reductions in Disease Activity and Disability Progression in Relapsing Multiple Sclerosis |
Genentech |
|
Sun, 04/15/2018 - 00:14 |
Genentech to Present New Data at AAN Highlighting Extensive Research for Ocrevus and Expanding Neuroscience Pipeline |
Genentech |
